HIGHLIGHTS
- who: Ali Abbara from the Cancer medical service, Japan University of Turku, Finland have published the paper: Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men, in the Journal: (JOURNAL)
- what: The authors evaluated the performance of the testicular markers INSL3 and INB in two cohorts; first in boys with delayed puberty due to either CHH or CDGP, and second in adult men with either CHH and eugonadal controls to determine the role of INSL3 and INB as biomarkers in CHH and delayed puberty. Consistent with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.